DFG

Coinstore New Public Chain Forum “Finding the Future Alpha” Has Completed Successfully

Retrieved on: 
Monday, April 22, 2024

Singapore, April 22, 2024 (GLOBE NEWSWIRE) -- Global top crypto asset platform, Coinstore, held a new public chain forum called “Finding the Future Alpha - Will Solana lead the next boom? ''

Key Points: 
  • Singapore, April 22, 2024 (GLOBE NEWSWIRE) -- Global top crypto asset platform, Coinstore, held a new public chain forum called “Finding the Future Alpha - Will Solana lead the next boom? ''
  • Before the forum, Coinstore has rich experience in holding events,and has actively published Cryptalk and CS Connect events.To date, Coinstore held more than 30 Cryptalk, nearly 40 CS Connect and 22 Expo conferences.
  • This public chain forum will become a benchmark forum.
  • Coinstore will hold more forums and events in the future to promote the collision of technology, capital, and new ideas, and bring innovation to the crypto industry.

BioCorRx Appoints Renowned Investment and Capital Markets Executive Louis Lucido as President

Retrieved on: 
Tuesday, January 9, 2024

Additionally, the Company announced that Brady Granier has submitted his letter of resignation as President of BioCorRx Inc. and Chief Executive Officer of BioCorRx Pharmaceuticals, a subsidiary of the Company, effective January 31, 2024.

Key Points: 
  • Additionally, the Company announced that Brady Granier has submitted his letter of resignation as President of BioCorRx Inc. and Chief Executive Officer of BioCorRx Pharmaceuticals, a subsidiary of the Company, effective January 31, 2024.
  • Mr. Granier's resignation did not arise as a result of any disagreement with the Company nor BioCorRx Pharmaceuticals.
  • Lourdes Felix, CEO, CFO, and Director of BioCorRx Inc., commented, “I am pleased to announce Louis’ appointment to Interim President of BioCorRx effective immediately and his transition to President of BioCorRx in February.
  • Louis’ breadth of experience in corporate finance and capital markets will be invaluable as we execute our growth strategy and plan for a Nasdaq listing.”
    Mr. Lucido has been a Director of BioCorRx Inc. since March 1, 2019.

Flash News: OKX Ventures Announces Investment in StarryNift, a Gamified Metaverse Co-Creation Platform

Retrieved on: 
Thursday, December 7, 2023

SINGAPORE, Dec. 07, 2023 (GLOBE NEWSWIRE) -- OKX Ventures , the investment arm of leading Web3 technology company OKX , has issued updates for December 7, 2023.

Key Points: 
  • SINGAPORE, Dec. 07, 2023 (GLOBE NEWSWIRE) -- OKX Ventures , the investment arm of leading Web3 technology company OKX , has issued updates for December 7, 2023.
  • OKX Ventures Announces Investment in StarryNift, a Gamified Metaverse Co-Creation Platform
    OKX Ventures today announced that it has invested in StarryNift , an AI-powered co-creation metaverse that offers immersive 3D virtual experiences for gaming, creation and socializing.
  • StarryNift combines cutting-edge technology with innovative features to create a virtual world where users can connect, express themselves and explore endless possibilities.
  • At the same time, StarryNift is also a metaverse platform that integrates various worldviews, allowing users to experience different cultures and styles in different scenarios.

AM Best Affirms Credit Ratings of Delphi Financial Group, Inc. and Its Subsidiaries

Retrieved on: 
Wednesday, November 15, 2023

Concurrently, AM Best has affirmed the Long Term ICR of “a+” (Excellent) and the Long-Term Issue Credit Rating (Long-Term IR) of “a-” (Excellent) of DFG.

Key Points: 
  • Concurrently, AM Best has affirmed the Long Term ICR of “a+” (Excellent) and the Long-Term Issue Credit Rating (Long-Term IR) of “a-” (Excellent) of DFG.
  • The outlook of all these Credit Ratings (ratings) is stable.
  • For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best's Credit Ratings .
  • For information on the proper use of Best’s Credit Ratings, Best’s Performance Assessments, Best’s Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Best’s Ratings & Assessments .

Hitting the $70M Mark and Expanding: Stakk Ventures Launches a Multi-Brand Conglomerate

Retrieved on: 
Monday, September 4, 2023

The collective strength of these brands has created a robust network of partners and clients, including numerous Euronext-listed companies.

Key Points: 
  • The collective strength of these brands has created a robust network of partners and clients, including numerous Euronext-listed companies.
  • BME Consulting : A spend and procurement management advisory firm based in Lyon, France, boasting $17M in annual revenue and growing 80% year-over-year.
  • Ben Constanty, CEO of Stakk Ventures says:
    “Launching Stakk Ventures truly encapsulates all our aspirations.
  • Venture Studio: Focuses on the ideation, development, and market readiness of in-house startups, serving as an incubator for new business ventures.

Muon g-2 doubles down with latest measurement, explores uncharted territory in search of new physics

Retrieved on: 
Thursday, August 10, 2023

The Muon g-2 collaboration describes the result in a paper that they submitted today to Physical Review Letters.

Key Points: 
  • The Muon g-2 collaboration describes the result in a paper that they submitted today to Physical Review Letters.
  • In addition to the larger data set, this latest g-2 measurement is enhanced by updates to the Fermilab experiment itself.
  • In 2020, the Muon g-2 Theory Initiative announced the best Standard Model prediction for muon g-2 available at that time.
  • Until then, physicists have a new and improved measurement of muon g-2 that is a significant step toward its final physics goal.

Keysight Enabling University of Stuttgart to Advance 6G Integrated Circuits Research

Retrieved on: 
Tuesday, August 8, 2023

Keysight Technologies, Inc. (NYSE: KEYS) is enabling the University of Stuttgart to conduct foundational research essential to development of new integrated circuits (ICs) for 6G technology with the new Keysight 6G Vector Component Analysis (VCA) solution .

Key Points: 
  • Keysight Technologies, Inc. (NYSE: KEYS) is enabling the University of Stuttgart to conduct foundational research essential to development of new integrated circuits (ICs) for 6G technology with the new Keysight 6G Vector Component Analysis (VCA) solution .
  • This is the latest collaboration from Keysight and the University of Stuttgart’s long-time research relationship.
  • The collaboration has supported the University of Stuttgart in establishing Crosslink, a versatile multiplexing platform for synchronous time- and frequency-domain analyses of ultra-broadband communication channels.
  • The Keysight and University of Stuttgart collaboration supports a large-scale equipment initiative funded by the German Research Foundation (DFG).

Amylyx Pharmaceuticals to Host Virtual Webcast on AMX0035 Progressive Supranuclear Palsy (PSP) Program

Retrieved on: 
Wednesday, July 12, 2023

Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) today announced the Company will host a virtual webcast with Prof. Dr. Günter Höglinger, Director of the Department of Neurology at LMU Hospital, Ludwig-Maximilians-University (LMU) Munich, Germany, to discuss the treatment landscape for people living with progressive supranuclear palsy (PSP) and the Company’s clinical development plans for AMX0035 in PSP on July 26, 2023 at 1:30pm ET.

Key Points: 
  • Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) today announced the Company will host a virtual webcast with Prof. Dr. Günter Höglinger, Director of the Department of Neurology at LMU Hospital, Ludwig-Maximilians-University (LMU) Munich, Germany, to discuss the treatment landscape for people living with progressive supranuclear palsy (PSP) and the Company’s clinical development plans for AMX0035 in PSP on July 26, 2023 at 1:30pm ET.
  • Prof. Dr. Höglinger studied medicine and physics at the universities of Regensburg and Würzburg and earned his PhD in medicine, summa cum laude, in 2000.
  • Since 2011, he has held the Chair of the Department of Translational Neurodegeneration at the German Center for Neurodegenerative Diseases, DZNE.
  • For many years, Prof. Dr. Höglinger has been conducting translational research into tauopathies and was actively involved in many international clinical trials in PSP.

U.S. - China Trade War: Why Trump Tariffs Backfired – New EPoS Research Reveals

Retrieved on: 
Tuesday, June 13, 2023

In contrast, only 68 percent of China’s retaliatory tariffs were shouldered by Chinese importers, U.S. exporters paid the other 32 percent.

Key Points: 
  • In contrast, only 68 percent of China’s retaliatory tariffs were shouldered by Chinese importers, U.S. exporters paid the other 32 percent.
  • These are findings of the Discussion Paper “Who Pays for the Tariffs and Why?
  • A Tale of Two Countries” published by EPoS economic research center at the Universities of Bonn and Mannheim.
  • Access the full paper at: https://www.crctr224.de/en/research-output/discussion-papers/archive/202...
    EPoS is a cooperation of the universities Bonn and Mannheim, funded by the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG).

AM Best Affirms Credit Ratings of Delphi Financial Group, Inc. and Its Subsidiaries

Retrieved on: 
Thursday, November 17, 2022

The outlook of these Credit Ratings (ratings) is stable.

Key Points: 
  • The outlook of these Credit Ratings (ratings) is stable.
  • Concurrently, AM Best has affirmed the Long Term ICR of a+ (Excellent) and the Long-Term Issue Credit Ratings (Long-Term IR) of DFG.
  • For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best's Credit Ratings .
  • For information on the proper use of Bests Credit Ratings, Bests Performance Assessments, Bests Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Bests Ratings & Assessments .